Wikidata

(Q51763771)

English

A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer.

scientific article published on 18 March 2009

In more languages
default values for all languages
No label defined

No description defined

Statements

title
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19294387
retrieved
11 April 2018
reference URL
http://europepmc.org/abstract/MED/19294387

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q51763771&oldid=2211184320"